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This study was performed to assess the biological
significance of miR-210 in preeclampsia and small-
for-gestational-age (SGA) pregnancies. Placental miR-
210 expression was evaluated by quantitative RT-PCR
(RT-qPCR) in the following groups: i) appropriate-for-
gestational-age pregnancies (n  72), ii) preeclampsia
(n  52), iii) SGA (n  66), and iv)preeclampsia with
SGA (n  31). The effects of hypoxia (1% O2) on
miR-210 and iron-sulfur cluster scaffold homologue
(ISCU) expressions and miR-210 binding to ISCU 3=
UTR were examined in Swan 71 and BeWo cell lines.
Perls’ reaction (n  229) and electron microscopy
(n  3) were conducted to verify siderosis of tropho-
blasts. miR-210 expression was increased in pre-
eclampsia and SGA cases and was decreased with
birth weight and gestational age. In both cell lines,
miR-210 was induced by hypoxia, whereas ISCU ex-
pression was decreased. The luciferase assay con-
590firmed miR-210 binding to ISCU mRNA 3= UTR. RNA
interference knockdown of ISCU expression in Swan
71, but not in BeWo, cells resulted in autophagosomal
and siderosomal iron accumulation and a fourfold
decrease of Matrigel invasion (P  0.004). Placental
ISCU expression was decreased in preeclampsia (P 
0.002) and SGA (P  0.002) cases. Furthermore, he-
mosiderin-laden trophoblasts were more frequent in
the placental bed of preterm preeclampsia and/or
SGA births than in control cases (48.7% versus 17.9%;
P  0.004). Siderosis of interstitial trophoblasts is a
novel pathological feature of preeclampsia and SGA.
The findings herein suggest that ISCU down-regula-
tion by miR-210 perturbing trophoblast iron metabo-
lism is associated with defective placentation. (Am J
Pathol 2011, 179:590–602; DOI: 10.1016/j.ajpath.2011.04.035)
Preeclampsia is a major pregnancy disorder, affecting
5% to 8% of all pregnancies, and is associated with
increased maternal and perinatal morbidity.1,2 This dis-
order clearly has features of systemic inflammation and
endothelial dysfunction in the mother.3,4 Many studies5–7
have described changes of placental gene expression in
pregnancies affected with preeclampsia, notably in-
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doglin and soluble fms-like tyrosine kinase 1. A sequence
of events composed of shallow invasion of interstitial tro-
phoblasts, impaired physiological transformation of ma-
ternal spiral arteries, and subsequent placental under-
perfusion has been described as a key pathological
feature of preeclampsia.8–11 Huppertz12 recently defined
these pathological consequences as particular features of
early-onset preeclampsia, occurring before 34 weeks of
gestation, in contrast to late-onset disease. Accordingly,
placentas of preeclampsia cases display evidence of oxi-
dative and endoplasmic reticulum stress, as is the case with
fetal growth restriction.13,14 Small-for-gestational-age (SGA)
births are commonly associated with preeclampsia,15 and
this condition shares a fundamental pathological feature of
superficial implantation of the placenta, a major character-
istic of early-onset preeclampsia and SGA cases.9,12,16 Pre-
eclamptic women are 3.6 times more likely to have SGA
neonates compared with normotensive women.17
MicroRNAs (miRNAs) are small (21- to 23-nucleotide)
single-stranded RNA molecules that play an important
role in the post-transcriptional regulation of gene expres-
sion by promoting RNA instability or translational inhibi-
tion.18,19 Growing evidence indicates that miRNA expres-
sion profiles define clinicopathological phenotypes of
various human disorders.20–26 Two recent studies27,28
have shown up-regulation of placental miR-210 as a dis-
tinct feature of preterm or severe preeclampsia, suggest-
ing a role for miRNAs in the regulation of altered placental
gene expression in preeclampsia. Not surprisingly, miR-
210 is known as a master miRNA of hypoxic response, a
common component of the tumor microenvironment.
miR-210 expression has been induced by hypoxia in all
cell types tested29 in a hypoxia-inducible factor (HIF)-1–
dependent manner.30 Moreover, in their recent analysis
using Argonaute 2 immunoprecipitation, Huang et al31
also showed that HIF-1 regulates miR-210 expression in
various tumors and that most of 50 potential target genes
of miR-210 that were identified, such as HOXA1 and
FGFRL1, are not hypoxia-inducible genes. The study
clearly shows how HIF-1 indirectly affects expression of
genes through regulation of miR-210 expression.31
Preeclampsia and fetal growth restriction are more com-
mon in high-altitude regions. Zamudio et al32 indicated that
pregnancy at high altitude (3100 m) and chronic hypoxia in
vivo are associated with an increased expression of HIF-1,
resembling that of preeclampsia. Therefore, up-regulation
of miR-210 in preeclamptic placentas seems to be biolog-
ically relevant, yet functional targets of miR-210 in the pla-
centa have not been identified. The present study was per-
formed specifically to address the clinicopathological and
functional significance of miR-210 in preeclampsia and
SGA pregnancies across human gestation.
Materials and Methods
Patients and Tissue Materials
Tissue samples were retrieved from the Bank of Biologi-
cal Materials of the Perinatology Research Branch, Eu-nice Kennedy Shriver National Institute of Child Health and
Human Development, NIH, Department of Health and
Human Services (Bethesda, MD, and Detroit, MI). All
patients provided written informed consent for the collec-
tion of clinical data and tissue samples under protocols
approved by the Institutional Review Boards of the par-
ticipating institutions. For the analysis of miR-210 expres-
sion, placental paraffin blocks of term and preterm pla-
centas (N  221) from the following groups were
retrieved: i) appropriate-for-gestational age (AGA) with-
out preeclampsia (n  72), ii) preeclampsia (n  52), iii)
SGA (n  66), and iv) preeclampsia with SGA (n  31).
All patients were Hispanic women who were delivered of
a neonate at Sótero del Rio Hospital, Santiago, Chile.
For localization of miR-210 expression by in situ hybrid-
ization, the placenta from a case of preterm preeclamp-
sia with SGA (gestational age, 33.9 weeks) delivered at
Hutzel Women’s Hospital, Detroit, MI, was used. For im-
munoblotting of an iron-sulfur cluster scaffold homologue
(ISCU), snap-frozen placental tissues from 12 preterm
labor cases (median gestational age, 32.1 weeks; range,
24.6 to 34.4 weeks), 12 preterm preeclampsia with SGA
(n  2) or without SGA (n  10) cases (median gesta-
tional age, 32.9 weeks; range, 23.9 to 35.0 weeks), and
12 preterm SGA cases (median gestational age, 31.6
weeks; range, 27.4 to 35.7 weeks), delivered at Sótero
del Rio Hospital (n  24) or Hutzel Women’s Hospital
(n  12), were used. Among these cases, five were
also included in the analysis of miR-210 expression
(n  4) or iron deposition in the placental bed (n  1).
There was no difference in the median gestational age
among the groups.
For iron staining, placental sections obtained from 41
cases of preterm preeclampsia with SGA (n  19) or
without SGA (n  22) among the cases tested for miR-
210 expression previously described were used, and
placental bed biopsy materials were also retrieved from a
different patient population (N  229) whose placental
bed biopsy specimens were available. All patients with
placental bed biopsy specimens were delivered of a
neonate at Hutzel Women’s Hospital. The patient groups
were as follows: i) AGA without preeclampsia (n  121),
ii) preeclampsia (n  29), iii) SGA (n  36), and iv)
preeclampsia with SGA (n  43). The placental bed was
defined as biopsy specimens with proved superficial
myometrium containing interstitial or endovascular tro-
phoblasts.
Preeclampsia was defined as the new onset of hy-
pertension after 20 weeks of gestation (systolic or di-
astolic blood pressure 140 mm Hg or 90 mm Hg,
respectively, measured at two different time points, 4
hours to1 week apart), along with proteinuria (300 mg
in a 24-hour urine collection or two random urine spec-
imens obtained 4 hours to 1 week apart containing
1 by dipstick or one dipstick demonstrating 2
protein).2,33 An SGA neonate was defined by sonogra-
phy, with estimated fetal weight 10th percentile for
gestational age and confirmed by neonatal birth
weight.34,35
592 Lee et al
AJP August 2011, Vol. 179, No. 2Real-Time RT-qPCR
Ten serial paraffin curls (20-m thick) were obtained in a
1.5-mL Eppendorf tube (Thermo Fisher Scientific, Waltham,
MA) and deparaffinized using xylene. Total RNA was iso-
lated using the RecoverAll Total Nucleic Acid Isolation Kit
(Ambion Inc., Austin, TX), according to the manufacturer’s
instructions. RNA concentrations were measured using a
NanoDrop spectrophotometer (Thermo Fisher Scientific).
The total RNA of Swan 71 and BeWo cell lines was iso-
lated with TRI Reagent (Ambion Inc.). For the relative
quantification of miR-210 in placental tissues, 25 ng of
total RNA was reverse transcribed using the High Capac-
ity cDNA Reverse Transcription Kit (Applied Biosystems,
Framingham, MA); and the TaqMan MicroRNA Reverse
Transcription Kit (Applied Biosystems) was used for RT of 100
ng of the total RNA of Swan 71 and BeWo cells. miR-210
expression was determined by using TaqMan assays (Ap-
plied Biosystems), and the TaqMan assay custom designed
for 5S ribosomal RNA (4373043) was used for normalization.
Reactions were performed using a 7500 Fast Real-Time PCR
System (Applied Biosystems).
In Situ Hybridization
In situ hybridization for the localization of miR-210 expres-
sion was performed using frozen placental sections
(10-m thick) obtained from a case of preterm pre-
eclampsia with SGA delivered at the gestational age of
33.9 weeks. A double-labeled miR-210 locked nucleic
acid (LNA) probe was generated by 3=-DIG labeling of a
5=-DIG–labeled miR-210 miRCURY LNA probe (Exiqon,
Woburn, MA) using a DIG oligonucleotide tailing kit
(Roche, Mannheim, Germany). After fixation in 4% (w/v)
paraformaldehyde for 10 minutes, the sections were
acetylated using an acetylation solution (0.1 mol/L trieth-
anolamine, 0.2% HCl, and 0.6% acetic anhydride). After
proteinase K (5 g/mL) digestion for 5 minutes at room
temperature, the sections were incubated with hybridiza-
tion buffer [50% formamide, 5 standard saline citrate,
5 Denhardt’s solution, 200 g/mL yeast RNA, 500
g/mL salmon sperm DNA, 2% Roche blocking reagent,
0.25% 3-cholamidopropyl dimethylammonio-1-propane-
sulfonic acid (CHAPS), and 0.5% Tween 20] containing a
2 pmol/L probe for 5 minutes at 60°C, with further hybrid-
ization overnight at 37°C. The probes were denatured at
65°C for 5 minutes before application. After hybridization,
the slides were washed with 0.2 standard saline citrate
and 2% bovine serum albumin at 4°C for 5 minutes,
followed by incubation with 1:500 diluted alkaline phos-
phatase–conjugated anti-DIG antibody (Roche) at 37°C
for 30 minutes. The signal was detected by using the Fast
Red substrate system (Dako, Carpinteria, CA).
In Vitro Hypoxia of Swan 71 Trophoblast and
BeWo Choriocarcinoma Cell Lines
Swan 71 human first-trimester trophoblast cells36 were main-
tained in Dulbecco’s modified Eagle’s medium (Mediatech
Inc., Manassas, VA), and BeWo human choriocarcinoma cells
(American Type Culture Collection, Manassas, VA) were cul-tured in F12 (GIBCO, Carlsbad, CA). Both culture media were
supplemented with 10% fetal bovine serum (GIBCO). The
cells were exposed to hypoxia for 24 or 48 hours using a gas
mixture (5% CO2 and 1% O2 balanced with N2) in an auto-
mated ProOx 110 and ProCO2–110 controller–sealed hypoxia
chamber (BioSpherix, Lacona, NY). Cells were harvested for
RNA and protein isolation to assess the effects of hypoxia on
miR-210 and ISCU expression.
Immunoblotting
Total protein was obtained from liquid nitrogen–pulverized
snap–frozen placental tissues (n  36) or from Swan 71 and
BeWo cells using a radioimmunoprecipitation assay lysis buf-
fer (Sigma-Aldrich, St. Louis, MO) containing a proteinase in-
hibitor cocktail (Roche). Protein, 10 g, was electrophoresed
in a 12% SDS–PAGE gel (Bio–Rad, Hercules, CA) and elec-
troblotted to polyvinylidene difluoride membranes (Hybond–P;
GE Healthcare Life Sciences, Piscataway, NJ). After blocking
with 5% blotting grade blocker nonfat dry milk (Bio–Rad), the
membranes were probed with a rabbit polyclonal anti–
ISCU1/2 antibody (sc–28860; Santa Cruz Biotechnology Inc.,
Santa Cruz, CA), an anti–HPRT (hypoxanthine phosphoribo-
syltransferase) antibody (sc–20795; SantaCruzBiotechnology
Inc.), or a mouse monoclonal anti––actin antibody (A2228;
Sigma–Aldrich). The chemiluminescent signals were de-
tected using a ChemiGlow West kit (Alpha Innotech,
San Leandro, CA).
Luciferase Assay
To assess miR-210 binding to the 3= UTR of ISCU mRNA,
the ISCU 3= UTR DNA fragment (289 bp) was amplified by
PCR using human placental genomic DNA (forward primer:
5=–ATAATACTAGTCCAGCTGTTTCCCACCTGCTGTGCA-
GTC–3=; reverse primer: 5=–ATAATAAGCTTGGTAAAATT-
AGATACTTATGCACTTCAC–3=) and cloned into the
pGEM-T easy vector (Promega, Madison, WI). The se-
quence confirmed that the fragment was subcloned into
the pMIR-REPORT Reporter Vector (Ambion Inc.). For the
luciferase assay, 5  105 Swan 71 or BeWo cells were
split in 60-mm cell culture dishes and cotransfected with
10 nmol/L miR-210 precursor molecules or miRNA pre-
cursor molecule–negative control 1, pMIR–ISCU 3= UTR,
and pRL-SV40 (Promega) plasmid. Twenty–four hours
after transfection, Firefly and Renilla luciferase activities
were measured using the Dual–Luciferase Assay Re-
agent II (Promega). All experiments were performed
three times, and Firefly luciferase activity was normalized
to the activity of the Renilla luciferase.
Transfection of Pre–miR-210 or Knockdown of
ISCU by RNA Interference
To determine the effects of miR-210 on ISCU expression,
5.0  105 Swan 71 or BeWo cells were split in a 60-mm
cell culture dish and transfected with 10 nmol/L pre–miR-
210 (Ambion Inc.) using the siPORT NeoFX Transfection
Agent (Ambion Inc.). Control cells were transfected with
miRNA precursor molecule–negative control 1 (Ambion
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and protein lysates were obtained with a radioimmuno-
precipitation assay lysis buffer (Sigma–Aldrich) for immu-
noblotting. For ISCU knockdown with the short hairpin
RNA (shRNA) vector, 3.5  105 Swan 71 or BeWo cells
were transfected with the pRS vector containing HuSH
29–mer anti–ISCU shRNA construct or pRS with a non-
effective green fluorescent protein shRNA cassette (Ori-
gene, Rockville, MD) using a transfection reagent previ-
ously described. After 48 hours, the changes in ISCU
protein expressions were evaluated by immunoblotting.
Control and ISCU knocked–down Swan 71 or BeWo cells
were subsequently subjected to Matrigel invasion assay
(BD Bioscience, Sparks, MD), Perls’ iron staining, and
transmission electron microscopic examination.
Matrigel Invasion Assay
Matrigel was diluted to 20 g/mL in cold PBS, and 100 L
of diluted Matrigel was added to each insert (BD Biosci-
ence) installed in a 24–well plate. Matrigel was allowed to
polymerize for 4 hours at 37°C. In each insert, 5  104
cells in 500 L of serum–free medium were seeded, and
500 L of medium with 5% fetal bovine serum were
added to the wells containing the inserts. After 24 hours,
the cells were fixed and stained using a Diff–Quik Stain
Figure 1. Placental expression of miR-210 determined by RT-qPCR. A: SGA
and 3.1-fold increases in placental miR-210 expression with respect to contro
miR-210 expression in PE cases between 26 and 38 weeks of gestation by 61
Table 1. Demographic and Clinical Characteristics of the Study P
Characteristics AGA (n  72) SG
Maternal age (years) 27 (17–45) 2
Nulliparity* 19 (26.4) 4
Smoking* 11 (15.3) 1
Body mass index (kg/m2) 24.2 (19.0–29.5) 22.
Gestational age at delivery
(weeks)
38.6 (28.1–41.6) 39.
Birth weight (g) 3305 (1140–4470) 256
Data are given as median (range) unless otherwise indicated.
*Data are given as number (percentage) of subjects.difference after 38 weeks of gestation. C: Inverse relationship between placental mi
For every kilogram increase in birth weight, miR-210 expression was decreased bySet (Dade Behring Inc., Newark, DE). The number of cells
that penetrated through Matrigel in each insert was
counted in three high–power fields using an inverted
microscope. The experiments were performed three
times in duplicate.
Perls’ Reaction
Hypoxia–exposed and anti–ISCU shRNA or control vec-
tor–transfected Swan 71 or BeWo cells were treated with
ammonium iron citrate (100 g/mL) for 24 hours. After
fixation with 4% paraformaldehyde, the cells were stained
with Perls’ solution. For the enhancement of iron staining
signals, the cells were incubated with 0.75 mg/mL 3,3=–
diaminobenzidine (Sigma–Aldrich) and 0.07% H2O2 in 1
mol/L Tris–HCl (pH 7.5) for 5 minutes, followed by rinsing
with PBS. For the demonstration of iron in the tissues, a
Perls’ reaction was performed with an iron staining kit
(Richard–Allan Scientific, Kalamazoo, MI), according to
the manufacturer’s instructions, using formalin–fixed par-
affin sections (5–m thick).
Transmission Electron Microscopy
Hypoxia–exposed or ISCU knocked–down Swan 71 or
BeWo cells for electron microscopic examination were
ampsia (PE), and PE with SGA pregnancies were associated with 1.6-, 1.9-,
. *P 0.01 compared with AGA. B: A linear model showing higher placental
43%, respectively, compared with those without PE (P  0.05). There is no
ion: Placental miR-210 Expression in 221 Subjects
66)
Preeclampsia
(n  52)
Preeclampsia with SGA
(n  31)
2) 24 (16–37) 25 (17–38)
) 32 (61.5) 19 (61.3)
) 4 (7.7) 3 (9.7)
–28.5) 24.1 (18.9–39.2) 24.3 (17.3–35.7)
–41.4) 37.3 (27.3–41.0) 36.3 (26.3–40.1)
–2950) 2840 (880–4270) 2040 (570–2960), preecl
ls (AGA)
3% andopulat
A (n 
3 (16–4
3 (65.2
3 (19.7
2 (17.4
1 (27.4
0 (640R-210 expression and birth weight in combined cases with and without PE.
approximately 35% (P  0.001).
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stained with 1% OsO4 for 1 hour and then dehydrated
through graded ethanol. After treatment with propylene
oxide, the cells were subjected to epoxy resin infiltration.
Placental bed tissues in paraffin blocks were deparaf-
finized using xylene and rehydrated through serial incu-
bations in graded ethanol. After rinsing with distilled wa-
ter, the samples were incubated with 0.1 mol/L
phosphate buffer (pH 7.4). Deparaffinized samples were
stained with 1% OsO4 for 1 hour and then dehydrated
through graded ethanol. Semi-thin sections of epoxy res-
in–embedded tissues were evaluated to locate the areas
with interstitial trophoblasts, and ultra-thin sections were
examined using a Hitachi 7100 transmission electron mi-
croscope (Hitachi High-Tech, Tokyo, Japan).
Statistical Analysis
The quantity Y  Ctmir210  Ctref was used as a surrogate
for the log2 expression level of miR-210 in each of the 221
samples that were analyzed by RT-qPCR. A linear model
was used to test for differences in miR-210 expression
among patients with and without preeclampsia, adjusting
for gestational age and birth weight at delivery. An inter-
action term was included in this model to assess whether
the rate of change of miR-210 expression differed among
clinical groups. A probability value was derived for each
term included in the model to assess the significance of
the estimated effects that were tested. All data analyses
were performed using the R statistical environment
(http://www.r-project.org). The Mann-Whitney U-test was
used to compare the results of densitometry of ISCU
Table 2. Effect of Advancing Gestational Age and Preeclampsia
on miR-210 Expression
Gestational age
(weeks) Fold change % Change P value
26 7.13 613.35 0.01
27 6.24 524.11 0.01
28 5.46 446.03 0.01
29 4.78 377.71 0.01
30 4.18 317.95 0.01
31 3.66 265.66 0.01
32 3.20 219.91 0.01
33 2.80 179.89 0.01
34 2.45 144.87 0.01
35 2.14 114.24 0.01
36 1.87 87.43 0.01
37 1.64 63.98 0.01
38 1.43 43.47 0.01
39 1.26 25.52 NS
40 1.10 9.82 NS
41 0.96 3.92 NS
42 0.84 15.94 NS
miR-210 expression in placentas with preeclampsia is increased be-
tween 26 and 38 weeks of gestation by 613% and 43%, respectively,
compared with those without preeclampsia. The magnitude of change in
miR-210 expression between groups decreases with advancing gesta-
tion. The percentage change indicates an increase or decrease in miR-
210 expression in placentas of patients with preeclampsia versus those
without preeclampsia. The differences reported are adjusted for birth
weight at delivery. Therefore, they represent differences between groups
at similar birth weights.
NS, not significant.expression, luciferase assay, and Matrigel invasion as-
say. Comparisons of positivity for Perls’ reaction in pla-
cental bed biopsy specimens between the control and
preeclampsia/SGA groups were performed using a 2 or
Fisher’s exact test. P 0.05 was considered significant in
all comparisons.
Results
Placental miR-210 Expression: Preeclampsia,
Birth Weight, and Gestational Age
The demographic characteristics of the study population
are summarized in Table 1. SGA, preeclampsia, and
Figure 2. Localization of miR-210 expression by in situ hybridization. A:
Strong miR-210 hybridization signals are detected in the interstitial tropho-
blasts (asterisks) of the basal plate (arrows). Hybridization signals are
stronger in the interstitial trophoblasts compared with those of villous tro-
phoblasts (arrowheads). Inset: Negative control (hybridization with scram-
ble control probe). B: In the chorionic villi, the miR-210 hybridization signal
is readily seen in the syncytiotrophoblast layer (arrows). Weak hybridization
signals are also detected in villous stromal cells and capillary endothelial
cells.preeclampsia with SGA pregnancies were associated
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210 expression when compared with controls, respec-
tively (Figure 1A). The linear model showed that placental
miR-210 expression is significantly higher in preeclamp-
sia cases between 26 and 38 weeks of gestation by
613% and 43%, respectively, compared with those with-
out preeclampsia (P  0.05; Table 2 and Figure 1B), but
not after 38 weeks of gestation. The magnitude of the
difference in miR-210 expression between preeclampsia
and nonpreeclampsia groups decreased with advancing
gestation, which was explained by increments in miR-210
expression at a rate of 8.6% per week in cases without
preeclampsia and decrements in miR-210 expression at
a rate of 5.0% per week in preeclampsia cases. Placental
miR-210 expression is inversely related to birth weight
in patients with and without preeclampsia. For every
kilogram increase in birth weight, miR-210 expression
was decreased by approximately 35% (P  0.001,
Figure 1C).
Hypoxia–Inducible miR-210 Targets ISCU in
Swan 71 Trophoblast and BeWo
Choriocarcinoma Cell Lines
In situ hybridization using an LNA probe specific for miR-
210 showed that miR-210 is primarily expressed in both
villous trophoblasts and extravillous interstitial tropho-
blasts, with far more distinct fluorescence in the latter
(Figure 2A). Weak miR-210 hybridization signals were
also detected in villous stromal cells and capillary endo-
thelial cells (Figure 2B). Because trophoblasts are the
primary population of cells expressing miR-210, we fur-
ther examined regulation of miR-210 by in vitro hypoxia
using the Swan 71 trophoblast cell line, established from
a human first–trimester placenta that has the character-istics of extravillous trophoblasts,36 and the BeWo cho-
riocarcinoma cell line, used in vitro to mimic syncytializa-
tion.37,38
miR-210 expression increased 8.9- and 2.1-fold in
Swan 71 and BeWo cell lines exposed to 1% O2 for 24
hours, respectively (P  0.05 for each, Figure 3A). A
search for putative targets of miR-210 using the Target-
Scan tool (http://www.targetscan.org, last accessed Jan-
uary 5, 2009) revealed ISCU to be among the top-pre-
dicted targets of miR-210. Immunoblotting of Swan 71
and BeWo cell lines incubated in 1% O2 showed de-
creased expression of predominantly the cytosolic iso-
form of ISCU after hypoxia (Figure 3, B and C). Further-
more, ISCU expression in primary villous placental
tissues was decreased in preeclampsia and SGA cases
(P  0.002 for each; Figure 3, D and E).
Based on the consistent inverse correlation between
miR-210 and ISCU expression patterns, a luciferase as-
say was conducted to determine whether miR-210 binds
to the 3= UTR of ISCU mRNA in Swan 71 and BeWo cells.
Transfection of Swan 71 and BeWo cells with pMIR-RE-
PORT-ISCU 3= UTR and precursor miR-210 resulted in a
33% and 29% reduction in luciferase activity, respec-
tively, indicating that miR-210 binds to ISCU 3= UTR in
both cell lines (P  0.05 for each, Figure 4A). Transfec-
tion of Swan 71 and BeWo cells with precursor miR-210
also decreased both cytosolic and mitochondrial iso-
forms of ISCU expression (Figure 4B). Experiments were
also performed to assess whether ISCU knockdown
could result in intracellular iron accumulation in tropho-
blasts. Transfection of Swan 71 and BeWo cells with
anti-ISCU shRNA significantly decreased ISCU protein
expressions (Figure 5, A and B) and resulted in coarsely
granular cytoplasmic iron accumulation only in ISCU-
Figure 3. miR-210 and ISCU expression in tro-
phoblast cell lines and placentas. A: Increased
expression of miR-210 by hypoxia (1% O2) in
Swan 71 human first-trimester trophoblast cells
and BeWo choriocarcinoma cells. miR-210 ex-
pression is increased by 8.9- and 2.1-fold after 24
hours of hypoxia in Swan 71 and BeWo cells,
respectively (*P  0.05 for each). B: Immuno-
blotting of hypoxia-treated Swan 71 and BeWo
cells showing decreased expression of both iso-
forms of ISCU. The change is more prominent in
cytosolic ISCU (c-ISCU) than in mitochondrial
ISCU (m-ISCU). C: Densitometric analysis of
ISCU expression shows a significant decrease of
ISCU in hypoxia-treated Swan 71 and BeWo
cells. D: Immunoblotting analysis showing de-
creased ISCU expression in villous placental tis-
sues obtained from preeclampsia (PE) and SGA
cases (P  0.002 for each). E: Densitometric
analysis of immunoblotting shows that ISCU ex-
pression is significantly decreased in PE and
SGA cases. Two cases in the PE group had con-
comitant SGA. The SGA group represents all
isolated cases without preeclampsia. All cases
are preterm cases. For densitometric analysis,
the sum of both cellular and mitochondrial ISCU
signals was compared. GA indicates gestational
age (weeks) at delivery; C, internal control.inhibited Swan 71 cells but not in BeWo cells, compared
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citrate (100 g/mL) treatment for 24 hours (Figure 5, A
and B). Swan 71 cells exposed to 1% O2 also showed
similar intracellular iron deposits but not in BeWo cells
(data not shown). For intracellular localization of iron accu-
mulation, electron microscopic examination of hypoxia-
treated and ISCU knocked-down Swan 71 cells was per-
formed. Iron was observed as electron-dense deposits in
membrane-bound lysosomes (siderosomes), whereas mi-
tochondrial iron deposition was not evident in hypoxia-
treated Swan 71 cells (Figure 5, C and D). Interestingly,
however, a few autophagosomes containing organelles
with electron-dense deposition were observed in the pe-
rinuclear regions of ISCU knocked-down Swan 71 cells
(Figure 5, E and F). The autophagosomes were not found
in BeWo cells (Figure 5, G and H).
Furthermore, the Matrigel invasion assay demon-
strated a 412% decrease in invasiveness of Swan 71
cells when ISCU is knocked down by shRNA, compared
Figure 4. miR-210 binding to ISCU mRNA 3= UTR in Swan 71 and BeWo cell
lines. A: Transfection of Swan 71 and BeWo cells with pMIR-REPORT-ISCU
3= UTR and precursor miR-210 resulted in a 33% and 29% reduction in
luciferase activity compared with the control group, respectively (*P  0.05
for each). B: Transfection of Swan 71 and BeWo cells with precursor miR-210
also decreases the expression of both cytosolic (c-) and mitochondrial (m-)
isoforms of ISCU. Swan 71 and BeWo cells were transfected with distilled
water (control 1), precursor miR-210 (premiR-210), or miRNA precursor
molecules–negative control (control 2).with the control cells (P  0.004; Figure 6, A and B).BeWo cells did not invade Matrigel, as expected; there-
fore, the effects of ISCU knockdown could not be com-
pared (Figure 6B).
Assessment of Iron Deposition in Trophoblasts
Intracellular accumulation of free iron has been docu-
mented in relatively rare human diseases originating from
defective iron-sulfur (Fe-S) cluster biogenesis.39–42 To
determine whether intracellular iron accumulation could
be found in trophoblasts of preeclampsia and SGA
cases, we examined placental sections obtained from 41
cases of preterm preeclampsia with SGA (n  19) or
without SGA (n  22), among the cases (Table 1) in
which miR-210 expression was assessed by RT-qPCR.
However, none of these cases showed iron deposition in
villous trophoblasts when Perls’ reaction was performed
using formalin-fixed, paraffin-embedded sections. In-
stead, focal punctate iron deposition in villous stromal
Figure 5. Intracellular iron deposition in ISCU knocked-down or hypoxia-
treated Swan 71 and BeWo trophoblast cells. A: Immunoblotting showing
decreased ISCU expression by anti-ISCU shRNA transfection. Granular cyto-
plasmic iron deposition is a characteristic of ISCU-inhibited Swan 71 cells.
The cells were treated with ammonium iron citrate (100 g/mL) for 24 hours.
Swan 71 cells exposed to 1% O2 also showed similar intracellular iron
deposits (data not shown). B: ISCU knockdown was not associated with
increased iron deposition in BeWo cells. Hypoxia (1% O2) also was not
associated with changes in iron deposition (data not shown). C–F: Ultrastruc-
tural features of hypoxia-treated (C and D) and ISCU knocked-down (E and
F) Swan 71 cells showing electron-dense deposits in membrane-bound lyso-
somes (siderosomes; arrowheads). Mitochondrial electron-dense deposits
were not evident, but autophagosomes (arrows) containing organelles with
electron-dense deposits were detected in the perinuclear region of ISCU
knocked-down Swan 71 cells. G and H: In BeWo cells, neither hypoxia (G)
nor ISCU (H) knockdown resulted in an increase of autophagosomes or
siderosomes.
a marke
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preeclampsia with SGA (Figure 7, A and B).
Based on the observation of in vitro (Swan 71 versus
BeWo cells) and villous placental iron staining patterns,
we further studied iron deposition in extravillous tropho-
blasts using placental bed biopsy specimens available
from an independent cohort of patients (n  229) who
represented preeclampsia, SGA, and control groups.
The demographics of this group of patients are summa-
rized in Table 3.
Perls’ reaction demonstrated intracellular hemosiderin
deposits in interstitial trophoblasts. These interstitial tro-
Figure 6. Decreased Matrigel invasion of Swan 71 trophoblasts. A: There is
with the control cells. B: A graph displaying a 412% decrease in invasivene
Figure 7. Iron deposition patterns in the villous placenta of preterm pre-
eclampsia cases with SGA. A: Punctate cytoplasmic iron deposition in stromal
and Hofbauer cells sp (arrows) of a stem villus embedded in a recent infarct
at the gestational age of 31.4 weeks. B: Another case showing punctate and
lacy Perls’ reaction in the villous stroma (arrows). The case was delivered at
the gestational age of 35.0 weeks.phoblastic iron deposits were more prominent in placen-
tal-site giant cells, and they appeared as crystalloid cy-
tosolic aggregations on Perls’ reaction (Figure 8, A and
B). The proportion of iron-positive cases was significantly
different between preeclampsia or SGA and gestational
age-matched nonpreeclamptic AGA cases (P  0.015).
A hemosiderin deposit was found in 48 (44.4%) of 108
cases of preeclampsia or SGA and 35 (28.9%) of 121
gestational age-matched nonpreeclamptic AGA cases.
When the cases were divided into preterm (n  106) and
term (n  123) cases, trophoblastic hemosiderin depo-
sition was more frequently found in preeclampsia or SGA
cases compared with control cases in preterm cases
[48.7% (38/78) versus 17.9% (5/28); P 0.004], whereas
the difference was not statistically significant in term
cases [33.3% (10/30) versus 32.3% (30/93)] (Figure 8C).
Transmission electron microscopy was performed in a
group of preeclampsia or SGA cases (n  3) to identify
the intracellular location (mitochondria versus cytosol) of
iron deposition. As was seen in Swan 71 cells, round to
oval, membrane-bound, electron-dense siderosomes were
found in the cytoplasm of trophoblasts (Figure 9), whereas
iron deposits were not observed inmitochondria. In contrast
to Swan 71 cells, autophagosomes were not detected in
interstitial trophoblasts under examination.
Discussion
The primary findings of this study are as follows: i) pla-
cental expression of miR-210 increases in preeclampsia
and is inversely related to birth weight and gestational
age; ii) hypoxia-inducible miR-210 targets 3= UTR of ISCU
mRNA in Swan 71 and BeWo trophoblast cell lines; iii)
hypoxia (1% O2) or ISCU knockdown results in sidero-
somal iron accumulation and the formation of autopha-
gosomes in Swan 71 trophoblast cells with extravillous
trophoblast characteristics but not in BeWo cells with a
potential for syncytialization; iv) ISCU knockdown mark-
edly decreases Matrigel invasion of Swan 71 cells; v) iron
deposition was not observed in villous trophoblasts of
placental tissues obtained from preterm preeclampsia,
with or without SGA cases (n  41); and vi) hemosiderin
deposition in the interstitial trophoblasts at the placental
bed is more frequent in preterm, but not term, preeclamp-
d decrease of Matrigel invasion in ISCU knocked down by shRNA compared
U knocked-down Swan 71 cells compared with control cells (P  0.004).sia or SGA pregnancies compared with control cases.
indicate
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as a cofactor in various cellular processes, such as res-
piration, oxygen transport, and DNA repair.43,44 Fe-S
clusters are prosthetic groups present in all life forms,
and the 2Fe-2S and 4Fe-4S clusters are common types.
These clusters, containing tetrahedrally coordinated iron
atoms and bridging sulfides, accept or donate single
electrons and thereby function as cofactors or regulatory
proteins.45 Because Fe-S clusters play a critical role in a
wide range of cellular activities, such as electron transfer
in oxidative phosphorylation and catalysis of enzymatic
reactions,46–48 perturbations in their biogenesis and re-
pair are detrimental to the cells. The critical nature of Fe-S
cluster biogenesis is evidenced by examples of human
disorders due to mutations of the genes involved in Fe-S
cluster biogenesis. Autosomal-recessive Friedreich’s
ataxia is a neurodegenerative disorder caused by a loss
of frataxin in the mitochondria. An intronic GAA triplet
expansion in the frataxin-encoding gene impedes tran-
scription elongation of frataxin, thus leading to its defi-
ciency.39,49 Sideroblastic anemia cases have a mutation
in the glutaredoxin-5 gene and subsequent mitochondrial
iron overload.40 Swedish myopathy is a disorder in which
Table 3. Demographic and Clinical Characteristics of the Study P
229 Subjects
Characteristics AGA (n  121) SG
Maternal age (years)* 25 (18–41) 2
Race
Black 108 (89.3) 3
White 6 (5.0)
Hispanic 2 (1.7)
Other 5 (4.1)
Nulliparity 30 (24.8) 1
Smoking 20 (16.5) 1
Body mass index (kg/m2)* 36.0 (22.1–64.1) 31.
Gestational age at delivery
(weeks)*
39.0 (23.4–42.0) 37.
Birth weight (g)* 3215 (530–3935) 243
Data are given as number (percentage) of subjects unless otherwise
*Data are given as median (range).
Figure 8. Iron deposition in interstitial trophoblasts of the placental bed of
B: Perls’ reaction showing intracellular hemosiderin deposits. The deposits
aggregations. Original magnification, 400. C: Hemosiderin in trophoblasts
preterm cases [48.7% (38/78) versus 17.9% (5/28); P  0.004], whereas there is no di
significant.ISCU expression is markedly decreased because of an
intronic G to C mutation in ISCU. This disorder is char-
acterized by muscle weakness, exercise-induced myo-
globinuria, and muscle iron overload.41,42 ISCU is a key
protein involved in Fe-S cluster biogenesis, and isoforms
originating from alternative splicing have been found in
the mitochondria and the cytosol, indicating that Fe-S
cluster biogenesis is a compartmentalized process in
mammalian cells.48,50 Impairment of cytosolic Fe-S clus-
ter assembly after selective depletion of cytosolic ISCU in
HeLa cells indicated that its function cannot be compen-
sated by mitochondrial ISCU.
Intracellular iron could be either heme or nonheme
iron, which is stored in ferritin or hemosiderin.51 The dis-
tinct and strong Perls’ reaction pattern in this study indi-
cates nonheme iron accumulation, and ultrastructural
patterns are consistent with siderosomes. It is particularly
intriguing that iron deposition is found in lysosomes (sid-
erosomes) but not in mitochondria of interstitial tropho-
blasts in the placental bed. Although all disorders of Fe-S
cluster biogenesis previously described are character-
ized by punctate mitochondrial iron deposits, significant
mitochondrial alterations were not found in the present
ion: Siderosis of Interstitial Trophoblasts in the Placenta Bed in
36)
Preeclampsia
(n  29)
Preeclampsia with SGA
(n  43)
2) 28 (16–41) 24 (15–43)
) 23 (79.3) 40 (93.0)
5 (17.2) 0 (0)
0 (0) 2 (4.7)
1 (3.4) 1 (2.3)
) 14 (48.3) 15 (34.9)
) 4 (13.8) 7 (16.3)
–55.8) 36.5 (19.0–65.1) 35.0 (20.4–55.4)
–40.4) 30.9 (23.9–39.0) 31.7 (24.0–40.6)
–2830) 1425 (640–3765) 1360 (327–2530)
d.
psia (A) and SGA (B) cases, both at the gestational age of 25 weeks. A and
re prominent in placental-site giant cells, appearing as crystalloid cytosolic
frequent in preeclampsia (PE)/SGA cases compared with control cases inopulat
A (n 
6 (15–4
1 (86.1
2 (5.6)
1 (2.8)
2 (5.6)
5 (41.7
1 (30.6
5 (20.3
1 (24.4
0 (350preeclam
are mo
is morefference in term cases [33.3% (10/30) versus 32.3% (30/93)]. NS indicates not
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heme and Fe-S cluster biosynthesis and also store iron in
mitochondrial ferritin. Mitochondria play a central role in
the regulation and integration of iron metabolism between
the mitochondria and cytosol.52 In Friedreich’s ataxia,
cytosolic iron is depleted because of increased expres-
sion of mitochondrial ferritin and subsequent mitochon-
drial iron overloading.53 Therefore, reconciliation of de-
creased placental ISCU expression and siderosomal iron
deposition in the present study is an intriguing challenge. A
recent study54 has shown increased autophagy in pre-
eclamptic placentas. Therefore, lysosomal uptake of iron-
containing macromolecules, such as ferritin and mitochon-
drial electron transport complex, by autophagy might be
one possible explanation.55 Our observation of Swan 71
cells showing autophagosomes containing membrane-
bound iron-laden organelles after ISCU knockdown strongly
supports this possibility, although the precise mechanisms
for an association between decreased ISCU expression
and siderosis of trophoblasts warrant further biological and
ultrastructural investigations.
The accumulation of intracellular iron and decreased
Matrigel invasion after ISCU inhibition by shRNA trans-
fection in Swan 71 trophoblasts strongly suggest that
Figure 9. Transmission electron microscopy placental bed biopsy specimen
from a preterm SGA case, shown in Figure 8B. A: Electron-dense lysosomal
iron deposits (siderosomes) in the cytoplasm of interstitial trophoblasts are
characteristic. Iron deposits are not observed in mitochondria. B: Close-up
image of siderosomes in the box shown above in Figure 9A.ISCU down-regulation by miR-210 could inhibit tropho-blastic invasion. A difference in the rate of positive Perls’
reactions of the placental bed biopsy materials between
control and preterm preeclampsia or SGA groups con-
fined to preterm cases is consistent with the trajectory of
placental miR-210 expression observed in the present
study. It can be argued that the patient populations an-
alyzed for placental miR-210 expression and trophoblas-
tic iron deposition are different in this study. The popula-
tions were different because placental bed biopsy
specimens were not available from those patients ana-
lyzed for placental miR-210 expression. However, we
originally found increased placental miR-210 expression
in women who were enrolled at the same institution where
the cases used for iron staining in this study were also
enrolled27; thus, our observation of association between
placental miR-210 and iron deposition is robust.
Recently, other investigators also have reported ISCU
regulation by miR-210 in different systems. Fasanaro et
al,56 using human embryonic kidney 293 cells, elegantly
demonstrated ISCUmRNA among enriched mRNAs in an
immunoprecipitated RNA-induced silencing complex
with an MYC (alias c-myc)–tagged Ago2 and loaded with
miR-210. Chan et al57 confirmed that miR-210 regulation
of ISCU in pulmonary arterial endothelial cells is impor-
tant in mitochondrial metabolism. Increased miR-210 ex-
pression after hypoxia is expected to confer to the cells
an adaptive survival advantage. In ischemic precondi-
tioned bone marrow–derived mesenchymal stem cells,
miR-210 protected the cells by targeting FLICE-associ-
ated huge protein/caspase-8–associated protein-2.58
ISCU regulation by miR-210 is also important in cancer
biology, with prognostic implications.59,60 However, the
findings in the present study clearly show that up-regu-
lation of miR-210 can affect the critical biological features
of the cells in distinct ways (eg, trophoblastic invasive-
ness necessary for successful placentation).
Histological changes of the placenta in preeclampsia
and SGA pregnancies, particularly in cases of early-onset
disease,12 have been largely attributed to maternal placen-
tal underperfusion.61 Burton et al62 recently showed that
defective conversion of spiral arteries would lead to villous
damage due to turbulent intervillous perfusion with high
momentum, instead of compromising the total volume of
blood flow, and to an increased risk of ischemia-reperfu-
sion injury and oxidative stress due to spontaneous va-
soconstriction. To our knowledge, we show for the first
time that increased siderosis of interstitial trophoblasts at
the placental bed is another novel pathological feature of
preterm preeclampsia and SGA pregnancies. The pres-
ence of hemosiderin is generally considered as evidence
of old hemorrhage,63 but our data strongly suggest that
siderosis of interstitial trophoblasts is a consequence of
nonhemorrhagic metabolic events, such as hypoxia and
oxidative stress. Other studies also have shown both
placental and systemic derangements of iron metabolism
in preeclamptic patients. A microarray analysis of placen-
tal gene expression demonstrated higher expression of
ceruloplasmin in patients with severe preeclampsia,
compared with control cases. With proven ferroxidatic
activity of this iron-transport protein, it was proposed that
up-regulation of ceruloplasmin is a protective mechanism
600 Lee et al
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et al65,66 reported elevated serum iron in preeclamptic
patients, which they attributed to increased red blood cell
turnover. Furthermore, serum levels of lipid peroxides, iron,
and ceruloplasmin in severe preeclampsia are elevated,
whereas the transferrin level was decreased; ischemic pla-
cental tissue was proposed to be a primary source of toxic
iron in preeclampsia.67
There are limitations of this study. First, although we
report a robust increase in miR-210 expression in the
villous placental tissues of preterm preeclampsia and
SGA cases, increased iron deposition in trophoblasts
after hypoxia and ISCU knockdown was found only in
Swan 71 cells with an extravillous trophoblast phenotype
and in placental bed interstitial trophoblasts. Justifica-
tion of our approach would require the demonstration
of decreased PO2 at the placental bed in preterm pre-
eclampsia and SGA cases. However, to our knowl-
edge, information on placental bed PO2 in preeclamp-
sia and SGA pregnancies is not available, whereas
there are seminal works on placental and endometrial
PO2 during pregnancy.
68,69 Instead, pathological stud-
ies70,71 have shown increased frequency of ischemic
coagulation necrosis of the decidua, known as laminar
necrosis or leukocytoclastic necrosis, in preeclampsia
and SGA cases. This strongly suggests that metabolic
stress is not restricted to the villous placenta but affects
uteroplacental compartments, such as the decidua and
the placental bed. In particular, Goldenberg et al70 have
shown, in their analysis of 446 placentas obtained from
consecutive singleton preterm births between 23 and 32
weeks of gestation, that women with diffuse decidual
leukocytoclastic necrosis of the decidua basalis are more
likely to have preeclampsia than others and that birth
weight is significantly lower in diffuse decidual leukocy-
toclastic necrosis–positive cases compared with diffuse
decidual leukocytoclastic necrosis–negative cases. Our
data also suggest that there is a difference in the sus-
ceptibility to perturbation in iron metabolism between vil-
lous and extravillous trophoblasts. Second, we could not
confirm the relationship between HIF-1 and miR-210
expression levels in the placenta. We have tried immu-
nohistochemical localization of HIF-1 in 41 cases of
preterm preeclampsia, with and without SGA, and none
of the cases showed significant immunoreactivity regard-
less of miR-210 expression level (data not shown). Third,
although we propose that iron deposition in interstitial
trophoblasts is involved in the pathogenesis of preterm
preeclampsia and SGA pregnancies, it is possible that it
is a consequence of defective placentation because we
could not investigate first-trimester tissue samples. Fi-
nally, an evaluation of the effects of hypoxia in two cell
lines in vitro might be a too simplistic approach, consid-
ering the controversies over the effects of hypoxia on
trophoblast invasion and complexities regarding the reg-
ulation of oxygen tensions in vitro.72
Collectively, preterm preeclampsia and SGA pregnan-
cies are unique examples of a human disorder with per-
turbed iron metabolism involving the interstitial tropho-
blasts at the fetomaternal interface because of epigenetic
alterations of the placenta: up-regulation of miR-210 tar-geting ISCU. This feature seems to be another patholog-
ical difference between early- and late-onset preeclamp-
sia and SGA pregnancies. The findings herein provide a
novel pathophysiological link between dysregulated ex-
pression of placental miRNA and pathogenesis of disor-
ders of deep placentation in human pregnancy.
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